![](/img/cover-not-exists.png)
Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation-positive lung cancer
Rotow, Julia K, Gui, Philippe, Wu, Wei, Raymond, Victoria M, Lanman, Richard B., Kaye, Frederic J, Peled, Nir, Fece de la Cruz, Ferran, Nadres, Brandon, Corcoran, Ryan B., Yeh, Iwei, Bastian, Boris C.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-1667
Date:
September, 2019
File:
PDF, 3.54 MB
english, 2019